• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Alphabet’s Verily, Wake Forest Baptist Health Partner on Healthy Aging Research

Share:

December 17, 2019

Highlights on this story:
  • Alphabet’s Verily is partnering with Wake Forest Baptist Health on a healthy aging research project to develop more effective ways to connect patients with healthcare professionals and the resources needed to better deliver long-term rather than episodic care.
  • The research partnership will test interventions that promote physical and cognitive independence and facilitate greater involvement of older adults in decisions related to their health and wellness preferences.

Verily, an Alphabet company is partnering with Wake Forest Baptist Health and its Center for Healthcare Innovation to implement new solutions to improve the health and wellness of older adults and help them remain independent at home.

“Keeping people healthy at home through all stages of life is foundational to our work at Verily,” said Vivian Lee MD, president of health platforms, Verily. “By partnering with Wake Forest Baptist, we can provide new monitoring and collaboration tools to patients and clinicians and will learn directly from their experience.”

Improve the Health and Independence of Older Adults

The research partnership will leverage Wake Forest Baptist’s unique expertise as a national leader in healthy aging and Alzheimer’s disease research and clinical care, with Verily’s expertise in product development and engineering. The partners aim to develop more effective ways to connect patients with health care professionals and the resources needed to better deliver long-term rather than episodic care.

As part of the research scope, the project will test interventions that promote physical and cognitive independence and facilitate greater involvement of older adults in decisions related to their health and wellness preferences. All interventions tested with patients will require Wake Forest Baptist’s Internal Review Board (IRB) approval, which is an established, rigorous process used for research at the health system today.

Why It Matters

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“We’re pleased to partner with Verily to assess technologies that will provide older adults with better access to healthcare and wellness without having to leave their homes,” said Jeff Williamson, M.D, chief of geriatric medicine and director, Center for Healthcare Innovation at Wake Forest Baptist Health. “The goal is to help this rapidly growing segment of our population to take an active role in living their most healthy and independent life in a familiar setting — their home.”

Verily’s partnership with Wake Forest builds off the company recent series of projects across clinical research and clinical care that are geared toward supporting ecosystem advancement for value-based care. Wake Forest Baptist joins Atrius Health, Veterans Administration Palo Alto and other progressive healthcare leaders who are part of this growing ecosystem.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • ONE HUNDRED And Gobel Group Form Strategic Partnership in Healthcare Philanthropic ConsultingONE HUNDRED And Gobel Group Form Strategic Partnership in Healthcare Philanthropic Consulting
  • Neuroflow, the Most “Clinical Grade” Out of “Sea of Mental Health Solutions,” Lands $7.5M InvestmentNeuroflow, the Most “Clinical Grade” Out of “Sea of Mental Health Solutions,” Lands $7.5M Investment
  • Health Note Raises $17M for Pre-Clinical Intake Automation PlatformHealth Note Raises $17M for Pre-Clinical Intake Automation Platform
  • MeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinson’s DiseaseMeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinson’s Disease
  • Akerna to Acquire Viridian SciencesAkerna to Acquire Viridian Sciences
  • 2020 Fortune/IBM Watson Health 100 Top Hospitals List2020 Fortune/IBM Watson Health 100 Top Hospitals List
  • The 53 Digital Health Mergers and Acquisitions We Covered in 2019The 53 Digital Health Mergers and Acquisitions We Covered in 2019
  • Bionoid Pharma Announces Letter of Intent to Acquire Global Alerts Corp.Bionoid Pharma Announces Letter of Intent to Acquire Global Alerts Corp.

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications